GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both ...

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. Read ...

A free webinar has encouraged medical device innovators to learn more about new Post-Market Surveillance (PMS) legislation ...

The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

Qlucore, a leader in software development for precision cancer diagnostics, received a prestigious grant of 2.5 million Euros during 2024. The grant is divided into four installments. The aim of the ...

Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, ...

INDIANAPOLIS, INDIANA / ACCESS Newswire / June 23, 2025 / 3Aware, a leading innovator in real-world evidence (RWE) solutions for the medical device industry, today announced the formation of its ...

On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of ...

A free-to-join webinar taking place at the end of June will encourage medical device innovators to learn more about new ...

A free to join webinar will encourage medical device innovators to learn more about new post-market surveillance legislation.